Aurinia Pharmaceuticals Inc (AUPH)

[Zeppo]

Okay......the Bloomburton update reminds us that VOC efficacy is real and outperforms another potential competitor, a huge global healthcare company. So now we have two competitors for two different indications where VOC is the superior product. We could surmise that Allergan and Roche are now potential suitors, yet I don't see how Allergan could afford the acquisition at this time.